2017論文

1	Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure. Rahman A, Hitomi H, Nishiyama A. Hypertens Res. 2017;40:535-540.
2	Effect of a selective SGLT2 inhibitor, luseogliflozin, on circadian rhythm of sympathetic nervous function and locomotor activities in metabolic syndrome rats. Rahman A, Fujisawa Y, Nakano D, Hitomi H, Nishiyama A. Clin Exp Pharmacol Physiol. 2017 Apr;44(4):522-525.
3	Exogenous thyroxine improves glucose intolerance in insulin-resistant rats. Vazquez-Anaya G, Martinez B, Sonanez-Organis JG, Nakano D, Nishiyama A, Ortiz RM. J Endocrinol. 2017 Mar;232(3):501-511.
4	Increase in tumor suppressor Arf compensates gene dysfunction in in vitro aged adipocytes. Hasan AU, Ohmori K, Hashimoto T, Kamitori K, Yamaguchi F, Konishi K, Noma T, Igarashi J, Yamashita T, Hirano K, Tokuda M, Minamino T, Nishiyama A, Kohno M. Biogerontology. 2017 Feb;18(1):55-68.
5	Hormonal changes following a low-salt diet in patients with Meniere’s disease. Miyashita T, Inamoto R, Fukuda S, Hoshikawa H, Hitomi H, Kiyomoto H, Nishiyama A, Mori N. Auris Nasus Larynx. 2017 Feb;44(1):52-57.
6	(Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway. Kouchi M, Shibayama Y, Ogawa D, Miyake K, Nishiyama A, Tamiya T. J Neurosurg. 2017 Jan 6:1-10.
7	An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model. Kobayashi R, Wakui H, Azushima K, Uneda K, Haku S, Ohki K, Haruhara K, Kinguchi S, Matsuda M, Ohsawa M, Toya Y, Nishiyama A, Yamashita A, Tanabe K, Maeshima Y, Umemura S, Tamura K. Kidney Int. 2017 May;91(5):1115-1125.
8	GPR120 in adipocytes has differential roles in the production of pro-inflammatory adipocytokines. Hasan AU, Ohmori K, Hashimoto T, Kamitori K, Yamaguchi F, Noma T, Igarashi J, Tsuboi K, Tokuda M, Nishiyama A, Kohno M. Biochem Biophys Res Commun. 2017 Apr 22;486(1):76-82.
9	The Relationship Between the Renin-Angiotensin-Aldosterone System and NMDA Receptor-Mediated Signal and the Prevention of Retinal Ganglion Cell Death. Kobayashi M, Hirooka K, Ono A, Nakano Y, Nishiyama A, Tsujikawa A. Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1397-1403.
10	Effects of sodium glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes. Yoshimoto T, Furuki T, Kobori H, Miyakawa M, Imachi H, Murao K, Nishiyama A. J Investig Med. 2017 Oct;65(7):1057-1061.
11	High salt intake reprioritizes osmolyte and energy metabolism for body fluid conservation. Kitada K, Daub S, Zhang Y, Klein JD, Nakano D, Pedchenko T, Lantier L, LaRocque LM, Marton A, Neubert P, Schroder A, Rakova N, Jantsch J, Dikalova AE, Dikalov SI, Harrison DG, Muller DN, Nishiyama A, Rauh M, Harris RC, Luft FC, Wassermann DH, Sands JM, Titze J. J Clin Invest. 2017 May 1;127(5):1944-1959.
12	Innovative delivery method using a detachable device to deliver a large polyglycolic acid sheet to a gastric ulcer perforation. Mori H, Kobara H, Rahman A, Nishiyama N, Nishiyama A, Suzuki Y, Masaki T. Endoscopy. 2017 Jul;49(7):E165-E167.
13	Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice. Tomita T, Arai S, Kitada K, Mizuno M, Suzuki Y, Sakata F, Nakano D, Hiramoto E, Takei Y, Maruyama S, Nishiyama A, Matsuo S, Miyazaki T, Ito Y. Sci Rep. 2017 Jul 25;7(1):6450.
14	IBMX protects human proximal tubular epithelial cells from hypoxic stress through suppressing hypoxia-inducible factor-1α expression. Hasan AU, Kittikulsuth W, Yamaguchi F, Ansary TM, Rahman A, Shibayama Y, Nakano D, Hitomi H, Tokuda M, Nishiyama A. Exp Cell Res. 2017 Sep 15;358(2):343-351.
15	How should we treat patients with primary aldosteronism to prevent new-onset diabetes mellitus? Hitomi H, Nishiyama A. J Hypertens. 2017;35(8):1575-1576.
16	Sodium intake affects gender difference in aldosterone concentration. Kitada K, Nishiyama A. Am J Physiol Renal Physiol. 2017 Aug 9;313:957-958.
17	Responses of renal hemodynamics and tubular functions to acute sodium-glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats. Ansary T, Fujisawa Y, Rahman A, Nakano D, Hitomi H, Kobara H, Masaki T, Titze JM, Kitada K, Nishiyama A. Sci Rep. 2017 Aug 25;7(1):9555.
18	A protease-activated receptor-1 antagonist protects against podocyte injury in a mouse model of nephropathy. Guan Y, Nakano D, Zhang Y, Li L, Liu W, Nishida M, Kuwabara T, Morishita A, Hitomi H, Mori K, Mukoyama M, Masaki T, Hirano K, Nishiyama A. J Pharmacol Sci. 2017 Sep 14. pii: S1347-8613(17)30128-7.
19	High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5. Wang J, Shibayama Y, Kobori H, Liu Y, Kobara H, Masaki T, Wang Z, Nishiyama A. PLoS ONE. 2017 Nov 9;12(11):e0187894.
20	Apoptosis inhibitor of macrophage depletion decreased M1 macrophage accumulation and the incidence of cardiac rupture after myocardial infarction in mice. Ishikawa S, Noma T, Fu H-Y, Matsuzaki T, Ishizawa M, Ishikawa K, Murakami K, Nishimoto N, Nishiyama A, Minamino T. PLoS ONE. 2017;12(11):e0187894.
21	Human pluripotent stem cell–derived erythropoietin-producing cells ameliorate renal anemia in mice. Hitomi H, Kasahara T, Katagiri N, Hoshina A, Mae S, Kotaka M, Toyohara T, Rahman A, Nakano D, Niwa A, Saito M, Nakata T, Nishiyama A, Osafune K. Sci Transl Med. 2017 Sep 27;9(409):eaaj230.
22	Glucose Suppresses Nrf2 Translocation and Increases Glutathione Levels in Diabetic Rat Hearts. Thorwald MA, Rodriguez GJ, Rodriguez MA, Godoy-Lugo JA, Nakano D, Nishiyama A, Forman HJ, Ortiz RM. Free Radical Biology and Medicine. 2017 Nov;112:156-157.
23	Expression of tissue (pro)renin receptor and concentrations of its soluble form in CSF in adult diffuse gliomas: Response. Kouchi M, Shibayama Y, Ogawa D, Miyake K, Nishiyama A, Tamiya T. Journal of Neurosurgery. 2017 Oct;127(4):963-964.